Frontiers in Immunology (Apr 2024)
B cells in the pneumococcus-infected lung are heterogeneous and require CD4+ T cell help including CD40L to become resident memory B cells
- Neelou S. Etesami,
- Neelou S. Etesami,
- Kimberly A. Barker,
- Kimberly A. Barker,
- Anukul T. Shenoy,
- Anukul T. Shenoy,
- Carolina Lyon De Ana,
- Carolina Lyon De Ana,
- Emad I. Arafa,
- Gabrielle N. Grifno,
- Adeline M. Matschulat,
- Adeline M. Matschulat,
- Michael E. Vannini,
- Riley M. F. Pihl,
- Michael P. Breen,
- Alicia M. Soucy,
- Wesley N. Goltry,
- Catherine T. Ha,
- Hanae Betsuyaku,
- Jeffrey L. Browning,
- Xaralabos Varelas,
- Xaralabos Varelas,
- Katrina E. Traber,
- Katrina E. Traber,
- Matthew R. Jones,
- Matthew R. Jones,
- Lee J. Quinton,
- Lee J. Quinton,
- Lee J. Quinton,
- Lee J. Quinton,
- Lee J. Quinton,
- Paul J. Maglione,
- Paul J. Maglione,
- Paul J. Maglione,
- Hadi T. Nia,
- Hadi T. Nia,
- Anna C. Belkina,
- Anna C. Belkina,
- Anna C. Belkina,
- Joseph P. Mizgerd,
- Joseph P. Mizgerd,
- Joseph P. Mizgerd,
- Joseph P. Mizgerd
Affiliations
- Neelou S. Etesami
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Neelou S. Etesami
- Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Kimberly A. Barker
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Kimberly A. Barker
- Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Anukul T. Shenoy
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Anukul T. Shenoy
- Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, United States
- Carolina Lyon De Ana
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Carolina Lyon De Ana
- Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Emad I. Arafa
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Gabrielle N. Grifno
- Department of Biomedical Engineering, Boston University College of Engineering, Boston, MA, United States
- Adeline M. Matschulat
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Adeline M. Matschulat
- Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Michael E. Vannini
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Riley M. F. Pihl
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Michael P. Breen
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Alicia M. Soucy
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Wesley N. Goltry
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Catherine T. Ha
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Hanae Betsuyaku
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Jeffrey L. Browning
- Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Xaralabos Varelas
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Xaralabos Varelas
- Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Katrina E. Traber
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Katrina E. Traber
- Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Matthew R. Jones
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Matthew R. Jones
- Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Lee J. Quinton
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Lee J. Quinton
- Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Lee J. Quinton
- Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Lee J. Quinton
- Division of Infectious Diseases and Immunology, University of Massachusetts Chan Medical School, Worcester, MA, United States
- Lee J. Quinton
- Department of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Paul J. Maglione
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Paul J. Maglione
- Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Paul J. Maglione
- Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Hadi T. Nia
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Hadi T. Nia
- Department of Biomedical Engineering, Boston University College of Engineering, Boston, MA, United States
- Anna C. Belkina
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Anna C. Belkina
- Department of Pathology and Laboratory Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Anna C. Belkina
- Flow Cytometry Core Facility, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Joseph P. Mizgerd
- Pulmonary Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Joseph P. Mizgerd
- Department of Virology, Immunology, and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Joseph P. Mizgerd
- Department of Biochemistry and Cell Biology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- Joseph P. Mizgerd
- Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States
- DOI
- https://doi.org/10.3389/fimmu.2024.1382638
- Journal volume & issue
-
Vol. 15
Abstract
Recovery from respiratory pneumococcal infections generates lung-localized protection against heterotypic bacteria, mediated by resident memory lymphocytes. Optimal protection in mice requires re-exposure to pneumococcus within days of initial infection. Serial surface marker phenotyping of B cell populations in a model of pneumococcal heterotypic immunity revealed that bacterial re-exposure stimulates the immediate accumulation of dynamic and heterogeneous populations of B cells in the lung, and is essential for the establishment of lung resident memory B (BRM) cells. The B cells in the early wave were activated, proliferating locally, and associated with both CD4+ T cells and CXCL13. Antagonist- and antibody-mediated interventions were implemented during this early timeframe to demonstrate that lymphocyte recirculation, CD4+ cells, and CD40 ligand (CD40L) signaling were all needed for lung BRM cell establishment, whereas CXCL13 signaling was not. While most prominent as aggregates in the loose connective tissue of bronchovascular bundles, morphometry and live lung imaging analyses showed that lung BRM cells were equally numerous as single cells dispersed throughout the alveolar septae. We propose that CD40L signaling from antigen-stimulated CD4+ T cells in the infected lung is critical to establishment of local BRM cells, which subsequently protect the airways and parenchyma against future potential infections.
Keywords